Blue Trust Inc’s SpringWorks Therapeutics SWTX Stock Holding History

Blue Trust Inc’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-21	Closed	-$987	–	2678
2025 Q2	$987	Hold	21	–	–	﹤0.01%	2253
2025 Q1	$927	Buy	+21	New	+$967	﹤0.01%	2306
2024 Q1	–	Sell	-51	Closed	-$1K	–	2676
2023 Q4	$1K	Buy	+51	New	+$1.33K	﹤0.01%	2416

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Blue Trust Inc's SWTX Position: Q3 2025 in Review

Blue Trust Inc sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 21 shares — an estimated $987 sold.

Blue Trust Inc first reported a position in SWTX in Q4 2023 and held it in 3 quarters. The position peaked at $1K in Q4 2023. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Blue Trust Inc reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Blue Trust Inc sold 21 SpringWorks Therapeutics shares in Q3 2025, an estimated $987.
Blue Trust Inc first reported a position in SpringWorks Therapeutics in Q4 2023 and held it in 3 quarters.
Blue Trust Inc's SpringWorks Therapeutics position peaked at $1K in Q4 2023.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Blue Trust Inc's 13F filing for Q3 2025, filed 16 Oct 2025.